Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5685043 | 0.92 | KMT2A (0.49) | KMT2AMEN1P2RX7HDAC1HDAC2 | |
| SCHEMBL5685372 | 0.92 | KMT2A (0.50) | KMT2AMEN1P2RX7HDAC1HDAC2 | |
| SCHEMBL5685018 | 0.92 | KMT2A (0.48) | KMT2AMEN1P2RX7HDAC1HDAC2 | |
| SCHEMBL5686001 | 0.92 | KMT2A (0.48) | KMT2AMEN1P2RX7HDAC1HDAC2 | |
| SCHEMBL5685476 | 0.92 | KMT2A (0.48) | KMT2AMEN1P2RX7HDAC1HDAC2 | |
| SCHEMBL5685459 | 0.91 | KMT2A (0.47) | KMT2AMEN1P2RX7HDAC1HDAC2 | |
| SCHEMBL5685815 | 0.91 | KMT2A (0.47) | KMT2AMEN1P2RX7HDAC1HDAC2 | |
| SCHEMBL5688209 | 0.91 | KMT2A (0.47) | KMT2AMEN1P2RX7HDAC1HDAC2 | |
| SCHEMBL68607 | 0.91 | KMT2A (0.47) | KMT2AMEN1P2RX7HDAC1HDAC2 | |
| SCHEMBL29419114 | 0.91 | KMT2A (0.47) | KMT2AMEN1P2RX7HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060122064-A1 | Amides and method for plant diseases control with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1640360-A1 | AMIDES AND METHOD FOR PLANT DISEASE CONTROL WITH THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122064-A1 | Amides and method for plant diseases control with the same | ARG1, ARGLU1, ARG2 | KMT2A 1374/4885MEN1 3091/4885P2RX7 4526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.